Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

Xiamen Amoytop Biotech Revenue

Xiamen Amoytop Biotech had revenue of 1.04B CNY in the quarter ending June 30, 2026, with 24.07% growth. This brings the company's revenue in the last twelve months to 4.02B, up 28.16% year-over-year. In the year 2025, Xiamen Amoytop Biotech had annual revenue of 3.70B with 31.18% growth.

• Revenue (ttm): 4.02B
• Revenue Growth: +28.16%
• P/S Ratio: 6.28
• Revenue / Employee: 1.10M
• Employees: 3,644
• Market Cap: 25.26B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.70B	878.41M	31.18%
Dec 31, 2024	2.82B	716.84M	34.13%
Dec 31, 2023	2.10B	573.42M	37.55%
Dec 31, 2022	1.53B	394.68M	34.86%
Dec 31, 2021	1.13B	338.29M	42.61%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error